[MYGN] QoQ Quarter Result on 31-Dec-2013 [#Q4]

Stock
[MYGN] Myriad Genetics, Inc.
Announcement Date
05-Feb-2014
Financial Year
2013
Quarter
31-Dec-2013 [#Q4]
Profit Trend
QoQ- -9.20%
YoY- 43.74%
Quarter Report
MYGN's Result
MYGN's Financial Summary
View:
Show?
Quarter Result
30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 CAGR
Revenue 168,837 188,765 182,924 204,060 202,467 174,116 156,472 5.19%
PBT 25,877 52,550 57,343 84,144 83,827 67,228 59,241 -42.40%
Tax 9,895 18,921 20,573 33,784 28,362 23,153 21,349 -40.08%
NP 15,982 33,629 36,770 50,360 55,465 44,075 37,892 -43.72%
Tax Rate -38.24% -36.01% -35.88% -40.15% -33.83% -34.44% -36.04% -
Total Cost 152,855 155,136 146,154 153,700 147,002 130,041 118,580 18.42%
Ratio Analysis
30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 CAGR
NP Margin 9.47 17.82 20.10 24.68 27.39 25.31 24.22 -46.49%
Per Share
30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 CAGR
EPS 0.22 0.45 0.50 0.67 0.70 0.55 0.47 -39.68%
EPS Diluted 0.21 0.43 0.48 0.66 0.68 0.53 0.46 -40.68%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.